RESUMO
BACKGROUND/AIMS: We previously found increased urinary protein excretion, glomerular filtration rate (GFR) and blood pressure in a retrospective analysis of patients with previous nephropathia epidemica (NE). Here, we evaluated the long-term outcome after NE in a prospectively recruited patient group. METHODS: Proteinuria, GFR and ambulatory 24-hour blood pressure were assessed 4-7 years (mean 6) after acute NE in 37 patients, and these values were compared to those from 38 seronegative controls. RESULTS: Six years after NE, the prevalence of elevated urinary alpha(1)-microglobulin excretion was higher in the patients than controls (9/35 vs. 1/38; p = 0.005). The patients also had higher urinary protein excretion (0.17 +/- 0.05 vs. 0.14 +/- 0.04 g/day; p = 0.006), GFR (119 +/- 19 vs. 109 +/- 14 ml/min/1.73 m(2); p = 0.016) and mean systolic (123 +/- 11 vs. 117 +/- 9 mm Hg; p = 0.012), nighttime systolic (109 +/- 11 vs. 100 +/- 9 mm Hg; p = 0.001) and nighttime diastolic blood pressure (70 +/- 7 vs. 66 +/- 7 mm Hg; p = 0.035) than the controls. CONCLUSIONS: These results confirm our previous findings of a higher prevalence of tubular proteinuria and increased urinary protein excretion, GFR and systolic blood pressure 6 years after acute NE.
Assuntos
Taxa de Filtração Glomerular , Febre Hemorrágica com Síndrome Renal/complicações , Febre Hemorrágica com Síndrome Renal/diagnóstico , Nefrite Intersticial/diagnóstico , Nefrite Intersticial/etiologia , Proteinúria/diagnóstico , Proteinúria/etiologia , Adulto , Idoso , Feminino , Humanos , Túbulos Renais Proximais/patologia , Estudos Longitudinais , Masculino , Pessoa de Meia-IdadeRESUMO
: Coagulation abnormalities are associated with Puumala-virus-induced hemorrhagic fever with renal syndrome (PUUV-HFRS). We evaluated the coagulation capacity of plasma during acute PUUV-HFRS by measuring thrombin generation using calibrated automated thrombography (CAT). The study cohort comprised 27 prospectively collected, consecutive, hospital-treated patients with acute PUUV infection. Blood samples were drawn in the acute phase and at the control visit approximately 5 weeks later. To evaluate thrombin generation, the lag time of initiation, endogenous thrombin potential (ETP), and peak and time to peak thrombin concentration were assessed by CAT in platelet poor plasma without corn trypsin inhibitor. Plasma levels of D-dimer, fibrinogen and prothrombin fragments (F1â+â2) were also evaluated. When the acute phase was compared with the control phase, ETP was decreased (median 1154ânmol/l/min, range 67-1785 vs. median 1385ânmol/l/min, range 670-1970; Pâ<â0.001), while the lag time was prolonged (median 3.8âmin, range 2.1-7.7 vs. median 2.9âmin, range 2.0-4.1; Pâ<â0.001). Low ETP correlated with low peak thrombin concentration (râ=â0.833, Pâ<â0.001). Prolonged time to peak associated with the lag time (râ=â0.78, Pâ<â0.001). ETP was associated with thrombocytopenia (râ=â0.472, Pâ=â0.015) and weakly with fibrinogen level (râ=â0.386, Pâ=â0.047). The measured CAT parameters did not associate with D-dimer and F1â+â2 levels. Decreased ETP together with low peak and prolonged lag time indicate decreased plasma potential for thrombin generation in vitro. Together with low platelet count and enhanced fibrinolysis, this further refers to altered blood coagulation and increased propensity toward bleeding in acute PUUV-HFRS.